Telix Price To Sales Ratio vs Free Cash Flow Per Share Analysis
| TLX Stock | 14.70 0.07 0.47% |
Telix Pharmaceuticals financial indicator trend analysis is much more than just breaking down Telix Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Telix Pharmaceuticals is a good investment. Please check the relationship between Telix Pharmaceuticals Price To Sales Ratio and its Free Cash Flow Per Share accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Price To Sales Ratio vs Free Cash Flow Per Share
Price To Sales Ratio vs Free Cash Flow Per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Telix Pharmaceuticals Price To Sales Ratio account and Free Cash Flow Per Share. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Telix Pharmaceuticals' Price To Sales Ratio and Free Cash Flow Per Share is 0.59. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Free Cash Flow Per Share in the same time period over historical financial statements of Telix Pharmaceuticals Limited, assuming nothing else is changed. The correlation between historical values of Telix Pharmaceuticals' Price To Sales Ratio and Free Cash Flow Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Telix Pharmaceuticals Limited are associated (or correlated) with its Free Cash Flow Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Per Share has no effect on the direction of Price To Sales Ratio i.e., Telix Pharmaceuticals' Price To Sales Ratio and Free Cash Flow Per Share go up and down completely randomly.
Correlation Coefficient | 0.59 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Telix Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Telix Pharmaceuticals sales, a figure that is much harder to manipulate than other Telix Pharmaceuticals Limited multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Most indicators from Telix Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Telix Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. Selling General Administrative is likely to drop to about 57.5 M in 2024. Sales General And Administrative To Revenue is likely to drop to 0.15 in 2024
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 5.2M | 6.4M | 13.1M | 7.1M | Depreciation And Amortization | 236.6K | 228.5K | 6.7M | 7.1M |
Telix Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Telix Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.